RxDoctor Payments Data

Nina Kahloon, MD

Dermatology · Louisville, KYNPI 1326136540

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 420 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.

$8,701in general payments, 2019–2025

Across 420 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merz North America, Inc.$1K
  • Lilly USA, LLC$778
  • Galderma Laboratories, L.p.$744
  • Johnson & Johnson$737
  • Sun Pharmaceutical Industries Inc.$592
  • plus $3K from 29 others

What the payments were for

  • Food & beverage$8,50298%
  • Education$2002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,701 in reported general payments places this provider in the 75th percentile of 128 dermatology providers in Kentucky.

See all dermatology providers in Kentucky

Medicare billing

Part B allowed, 2024
$199,750
Medicare patients
1,035
Services billed
3,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab38$168,431
Humira(Cf) PenAdalimumab15$101,958
Clobetasol Propionate76$3,120
Metronidazole60$2,471
Ketoconazole86$1,543
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc19$1,233
ValacyclovirValacyclovir Hcl40$962
Triamcinolone Acetonide98$716
Betamethasone Dipropionate15$637
Minoxidil75$526
Hydrocortisone108$431
Nystatin33$397
Hydroxyzine Hcl13$284
Mupirocin34$196
Doxycycline Hyclate15$193

Paid to pharmacies, not to this prescriber.

Other dermatology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →